Without more powerful serum markers, although imperfect, CA15-3 and CEA remain the most commonly used biomarkers in breast cancer and are recommended for practical use by the American Society of Clinical Oncology (ASCO). The gene discussed is CEACAM5; the disease is breast cancer.